1. 🎯 Phase Summary
| Phase | Phase 10 · v4.0 · Consumer + Enterprise Plus |
| Duration | 8 Jul - 20 Oct 2030 (15 weeks · 5 sprints × 3 weeks) |
| Goal | Consumer mobile app launch · 50+ enterprise wellness clients · 5+ pharma trials live · ASEAN healthcare AI standard published · scale 500 → 1,000+ tenants |
2. 🎨 Themes
- Consumer-direct B2C — MediEco mobile app on App Store + Play Store · self-triage · book any panel clinic · personal health record · medication reminders · health goals. Free tier + paid premium. Patient-acquired clinics flip from B2B to B2C2B funnel.
- Enterprise wellness B2B — Employer wellness programs — Khazanah · Petronas · Maybank · CIMB · Telekom · MOH itself. Annual screening · executive health · mental wellness · chronic disease management. Per-employee subscription model.
- Clinical research recruitment — De-identified consented patient pool for RCTs · IRB-approved · MOH research permits · GCP-compliant. Universities + pharma companies recruit eligible patients via opt-in.
- Pharma trial network — Phase II-IV trials hosted on MediEco · per-site digital protocol · adverse event monitoring · regulatory reporting. Start with 5 trials, scale to 20+ in 2031.
- ASEAN healthcare AI standard — Public technical standard for clinical AI safety in ASEAN — Doc Zam-authored · adopted by MOH-MY · proposed to ID/TH/VN. MediEco becomes reference implementation. Open-source the standard, not the proprietary platform.
3. 🏃 Sprint Catalog
10.1
Consumer-Direct Mobile App
8 - 28 Jul 2030
Native iOS + Android · self-triage · panel clinic booking · personal health record · medication reminders · free + premium tiers
10.2
Employer Wellness Program
29 Jul - 18 Aug 2030
Per-employee subscription · annual screening · executive health · mental wellness program · 5 anchor enterprise clients
10.3
Clinical Research Platform (RCT)
19 Aug - 8 Sep 2030
De-identified patient pool · IRB workflows · MOH research permit · GCP-compliant · 3 university partners
10.4
Pharma Trial Network
9 - 29 Sep 2030
5 active trials · per-site digital protocol · adverse event monitoring · regulatory reporting · pharma BD
10.5
ASEAN Healthcare AI Standard + v4.0 Closeout
30 Sep - 20 Oct 2030
Public technical standard · MOH-MY adoption · ASEAN proposal · 1000-tenant celebration · v5.0 plan
5. 📊 Success Metrics
1,000+
Tenants live across ASEAN
100K+
Consumer app downloads (Y1)
50+
Enterprise wellness clients
5+
Active pharma trials
1
ASEAN healthcare AI standard published
21+
Specialty modules deployed
6. 🚪 Phase Exit Criteria
- Consumer mobile app live on both stores · ≥ 100K downloads · ≥ 30K active users
- 50+ enterprise wellness contracts signed · ARR ≥ RM 12M
- 5+ pharma trials live · IRB-approved · GCP audit clean
- ASEAN healthcare AI standard v1.0 published · MOH-MY adoption letter
- 1,000+ tenants live across MY/ID/TH/VN/+
- External pen-test + clinical safety audit v4.0 clean reports
- Doc Zam keynote at 1000-tenant celebration · public ASEAN platform attestation
7. 🔮 Beyond This Phase
v5.0 (post-2030) considers global expansion — South Asia + MENA + Africa. ALESA + MediEco become joint reference architecture. Continue self-evolution per ALESA v18.6.0 doctrine. The 4-year journey from Doc Zam approval to ASEAN platform is complete.